Merck Zocor Rhabdomyolysis Risk Is Dose-Related, Revised Warning Says

The risk of myopathy and rhabdomyolysis associated with Merck's Zocor (simvastatin) increases in proportion to the dose, revised labeling says

More from Archive

More from Pink Sheet